Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucile Amrouche

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|December 20, 2018
No clinical benefit of rapid versus gradual tapering of immunosuppression to treat sustained BK virus viremia after kidney transplantation: a single-center experienceArnaud Devresse, Claire Tinel, Agathe Vermorel, et al.
Transplantation|February 12, 2020
Efficacy and Safety of Direct Oral Anticoagulants in Kidney Transplantation: A Single-center Pilot ExperienceJuliette Leon, Laurent Sabbah, Olivier Aubert, et al.
Journal of the American Society of Nephrology : JASN|July 23, 2016
MicroRNA-146a in Human and Experimental Ischemic AKI: CXCL8-Dependent Mechanism of ActionLucile Amrouche, Geoffroy Desbuissons, Marion Rabant, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 7, 2020
Increased incidence and unusual presentations of CMV disease in kidney transplant recipients after conversion to belataceptNathalie Chavarot, Gillian Divard, Anne Scemla, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 7, 2021
A kidney discard decision strategy based on zero-time histology analysis could lead to an unjustified increase in the organ turndown rate among ECDYosu Luque, Matthieu Jamme, Olivier Aubert, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 24, 2018
Reduction in late onset cytomegalovirus primary disease after discontinuation of antiviral prophylaxis in kidney transplant recipients treated with de novo everolimusArnaud Devresse, Marianne Leruez-Ville, Anne Scemla, et al.
Scientific Reports|November 1, 2019
MicroRNA-146a-deficient mice develop immune complex glomerulonephritisLucile Amrouche, Sylvaine You, Virginia Sauvaget, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 12, 2022
Severe relapse of SARS-CoV-2 infection in a kidney transplant recipient with negative nasopharyngeal SARS-CoV-2 RT-PCR after rituximabAntoine Morel, Sandrine Imbeaud, Anne Scemla, et al.
Nephrologie & Therapeutique|December 3, 2014
[Current aspects of acute humoral rejection]Christophe Legendre, Alexandre Loupy, Marion Rabant, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 25, 2021
Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belataceptNathalie Chavarot, Antoine Morel, Marianne Leruez-Ville, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Transplant International : Official Journal of the European Society for Organ Transplantation|December 20, 2018
No clinical benefit of rapid versus gradual tapering of immunosuppression to treat sustained BK virus viremia after kidney transplantation: a single-center experienceArnaud Devresse, Claire Tinel, Agathe Vermorel, et al.
Transplantation|February 12, 2020
Efficacy and Safety of Direct Oral Anticoagulants in Kidney Transplantation: A Single-center Pilot ExperienceJuliette Leon, Laurent Sabbah, Olivier Aubert, et al.
Journal of the American Society of Nephrology : JASN|July 23, 2016
MicroRNA-146a in Human and Experimental Ischemic AKI: CXCL8-Dependent Mechanism of ActionLucile Amrouche, Geoffroy Desbuissons, Marion Rabant, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 7, 2020
Increased incidence and unusual presentations of CMV disease in kidney transplant recipients after conversion to belataceptNathalie Chavarot, Gillian Divard, Anne Scemla, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 7, 2021
A kidney discard decision strategy based on zero-time histology analysis could lead to an unjustified increase in the organ turndown rate among ECDYosu Luque, Matthieu Jamme, Olivier Aubert, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 24, 2018
Reduction in late onset cytomegalovirus primary disease after discontinuation of antiviral prophylaxis in kidney transplant recipients treated with de novo everolimusArnaud Devresse, Marianne Leruez-Ville, Anne Scemla, et al.
Scientific Reports|November 1, 2019
MicroRNA-146a-deficient mice develop immune complex glomerulonephritisLucile Amrouche, Sylvaine You, Virginia Sauvaget, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 12, 2022
Severe relapse of SARS-CoV-2 infection in a kidney transplant recipient with negative nasopharyngeal SARS-CoV-2 RT-PCR after rituximabAntoine Morel, Sandrine Imbeaud, Anne Scemla, et al.
Nephrologie & Therapeutique|December 3, 2014
[Current aspects of acute humoral rejection]Christophe Legendre, Alexandre Loupy, Marion Rabant, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 25, 2021
Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belataceptNathalie Chavarot, Antoine Morel, Marianne Leruez-Ville, et al.
Pageof 4